Merck has reported financial results that exceed market expectations, indicating a strong performance in certain areas.
However, the results from its growth products have been mixed, raising questions about their future trajectory.
Investors and analysts will likely be closely monitoring these developments as they assess the overall health of Merck's product portfolio.